Liraglutide Best at Reducing A1c’s When Used in a Two-Drug Combo

The mean weight loss benefit for patients on the liraglutide-glimepiride combination was more than 2 kilograms (about 4.5 pounds) greater than that for patients on glimepiride-rosiglitazone. (Liraglutide molecule path pictured)

Feb 19, 2009

Data from a phase 3 study of the Novo Nordisk drug liraglutide shows that when it is used in combination with glimepiride, it is more effective at reducing A1c's than glimepiride by itself or glimepiride in combination with the drug rosiglitazone. 

A phase 3 study is the last step before a drug receives approval from government agencies to go to market. Novo Nordisk currently has applications before the U.S. Food and Drug Administration, the European Medicines Agency, and the Japanese government for approval to market liraglutide as a treatment for type 2 diabetes

Researchers conducted a 26-week double-blind trial with more than 2,000 type 2 patients. Patients were randomly selected to receive one of the following treatments:

  • Liraglutide (in either 1.2 mg or 1.8 mg doses) in combination with glimepiride
  • Rosiglitazone in combination with glimepiride 
  • Placebo

By the end of the study, patients on the liraglutide-glimepiride combination experienced a 1.08 percent (1.2 mg dose group) and 1.13 percent (1.8 mg dose group) reduction in their baseline A1c's, compared to a 0.44 percent reduction in the glimepiride-rosiglitazone group.

The mean weight loss benefit for patients on the liraglutide-glimepiride combination was more than 2 kilograms (about 4.5 pounds) greater than that for patients on glimepiride-rosiglitazone. 

Liraglutide is a glucagon-like peptide-1 analog that stimulates the release of insulin when blood sugar levels are elevated and inhibits the release of glucagon from the liver. Taken once daily by injection, the drug often leads to weight loss in patients because it slows gastric emptying, thus delaying the onset of hunger pangs.

A drug like liraglutide is often the second drug that doctors prescribe for type 2s as their disease progresses. Typically, newly diagnosed types 2s start with metformin, which may later be joined by a sulfonylurea like glimepiride.

Click Here To View Or Post Comments

Categories: A1c Test, Blood Sugar, Diabetes, Diabetes, Food, Insulin, Medications Research, Novo Nordisk, Professional Issues, Type 2 Issues, Type 2 Medications


Diabetes Health Professional
Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.